Symptoms and screening for prostate cancer
This article was originally published in Clinica
In the US, men in their 50s and 60s are screened to identify prostate cancer in its early stages. Raised blood levels of prostate specific antigen serve as predictors of tumorous activity in the prostate. However, research has shown that this test is inaccurate - picking up only 30-40% of tumours. That inaccuracy also means that many relatively harmless, slow-growing tumours are treated aggressively.
You may also be interested in...
The European Court of Justice has confirmed the European Medicines Agency’s approach to disclosure of data submitted as part of a marketing authorization application. It is a big disappointment for industry, which nonetheless says it supports responsible data sharing and will support efforts to develop a balanced approach.
Dr Reddy’s sees its Indian domestic market and China as hot prospects as it pursues its “transformation journey” in which it is reducing its dependence on the slowing US market.